Abstract:Cancer has thwarted as a major health problem affecting the global population. With an alarming increase in the patient population suffering from diverse varieties of cancers, the global demographic data predicts sharp escalation in the number of cancer patients. This can be expected to reach 420 million cases by 2025. Among the diverse types of cancers, the most frequently diagnosed cancers are the breast, colorectal, prostate and lung cancer. From years, conventional treatment approaches like surgery, chemotherapy and radiation therapy have been practiced. In the past few years, increasing research on molecular level diagnosis and treatment of cancers have significantly changed the realm of cancer treatment. Lately, uses of advanced chemotherapy and immunotherapy like treatments have gained significant progress in the cancer therapy, but these approaches have several limitations on their safety and toxicity. This has generated lot of momentum for the evolution of new drug delivery approaches for the effective delivery of anticancer therapeutics, which may improve the pharmacokinetic and pharmacodynamic effect of the drugs along with significant reduction in the side effects. In this regard, the protein-based nano-medicines have gained wider attention in the management of cancer. Proteins are organic macromolecules essential, for life and have quite well explored in developing the nano-carriers. Furthermore, it provides passive or active tumour cell targeted delivery, by using protein based nanovesicles or virus like structures, antibody drug conjugates, viral particles, etc. Moreover, by utilizing various formulation strategies, both the animal and plant derived proteins can be converted to produce self-assembled virus like nano-metric structures with high efficiency in targeting the metastatic cancer cells. Therefore, the present review extensively discusses the applications of protein-based nano-medicine with special emphasis on intracellular delivery/drug targeting ability for anticancer drugs.

Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles.

Protein Nanoparticles Directed Cancer Imaging and Therapy

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force

Nanocarriers for intracellular delivery of proteins in biomedical applications: strategies and recent advances

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery

Nanoparticle‐Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions

Nanoparticle-based materials in anticancer drug delivery: Current and future prospects

Nanomaterials in Cancer-Therapy Drug Delivery System

Polypeptides-Based Nanocarriers in Tumor Therapy

Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics

Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review

Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies

Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy

Advanced materials for co-delivery of drugs and genes in cancer therapy

The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment

Nanomaterial-Based Drug Delivery Systems: A New Weapon for Cancer Immunotherapy

Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies

Nanoparticle-based medicines in clinical cancer therapy

Simple and Efficient Targeted Intracellular Protein Delivery with Self‐Assembled Nanovehicles for Effective Cancer Therapy